background noncyst fibrosis bronchiectasi chronic structure lung conduit cours recur infect exacerb lead frequent antibiotic treatment make popup suspect acquire pathogen resist aim investing risk factor assoc iso multidrugresist method prospect observe studi conduct two tertiarycar host enroll patient first exacerb appear multidrugresist determine accord european center disease prevent control classis result under thirty three include microorgan iso episode found pseudomona aeruginosa methicillinresist staphylococcu aureus extend spectrum betalactamas enterobacteriacea require host v p indeed renal disease odd ratio ci previous year prior roport follow without factor concur identify inform may assist clinician choose empire antibiotic daily clinic practice 